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The central role of mitochondria in metabolic pathways and in cell death mechanisms requires 
sophisticated signaling systems. Essential in this signaling process is an array of lipid mediators 
derived from polyunsaturated fatty acids. However, the molecular machinery for the production of 
oxygenated polyunsaturated fatty acids is localized in the cytosol and their biosynthesis has not 
been identified in mitochondria. Here we report that a range of diversified polyunsaturated 
molecular species derived from a mitochondria-specific phospholipid, cardiolipin, are oxidized by 
the intermembrane space hemoprotein, cytochrome c. We show that an assortment of oxygenated 
cardiolipin species undergoes phospholipase A2-catalyzed hydrolysis thus generating multiple 
oxygenated fatty acids, including well known lipid mediators. This represents a new biosynthetic 
pathway for lipid mediators. We demonstrate that this pathway including oxidation of 
polyunsaturated cardiolipins and accumulation of their hydrolysis products – oxygenated linoleic, 
arachidonic acids and monolyso-cardiolipins – is activated in vivo after acute tissue injury.
Mitochondria of eukaryotic cells contain machinery capable of oxidizing substrates in a 
coupled enzymatic and electrochemical process that effectively generates energy in the form 
of ATP. In addition to the powerhouse function, mitochondria are now viewed as the major 
regulatory platform involved in numerous intra- and extracellular metabolic and 
physiological pathways – from synthesis of major intracellular biomolecules to assembly of 
inflammasomes, immune responses, generation of reactive oxygen species, dynamic 
regulation of their own organization via fission/fusion and mitophagy as well as control and 
execution of apoptotic and necrotic cell death1. Although there is an intuitive necessity for 
the existence of specific signals for mitochondrial communications – the identification of 
these signals has not been fully achieved. An array of lipid mediators, with diversified and 
potent signaling effects on the normal homeostasis and responses to stress and disease, are 
generated through oxygenation of free polyunsaturated fatty acids (PUFA). Molecular 
machinery involved in the production of these bioactive oxygenated compounds has been 
mostly assigned to the cytosol2. Surprisingly, mitochondria have not been identified as a site 
of lipid mediators biosynthesis3.
The rate limiting step in the production of lipid mediators is the availability of oxidizable 
PUFA4. Normally esterified into cellular (phospho)lipids, free PUFA are released by Ca2+-
dependent phospholipases A2 (PLA2) and act as substrates for oxygenation reactions by 
several enzymes, including, cyclooxygenases (COX), lipoxygenases (LOX), cytochrome 
P450 isoforms, and peroxidases5. A plethora of lipid regulators including prostaglandins, 
prostacyclins, thromboxanes, resolvins, protectins, maresins, leukotrienes, lipoxines, 
lipoxenes, levulo-glandins, among others, with multitude of physiologic effects are 
formed6, 7. Notably, the major precursor of lipid mediators, phosphatidylserine (PS)8, is 
lacking from mitochondria9. The majority of phospholipids constituting the inner and outer 
mitochondrial membranes (IMM and OMM) are manufactured outside of the organelle, with 
a notable exception of mitochondria-specific cardiolipin (CL). CL (1,3-bis(sn-3’-
phosphatidyl)-sn-glycerol) is structurally unique as it contains two phosphatidyl groups 
linked to a glycerol backbone and four fatty acyl chains. With about 20 different, mostly 
PUFA residues available for esterification, the diversity of CLs and its oxygenated species 
may be very high thus making it an exceptionally good source of lipid mediators.
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The final rate-limiting step in the production of CL takes place in the IMM to which the 
newly synthesized CL molecules are sequestered thus generating characteristic CL 
asymmetry10. Collapse of CL asymmetry and accumulation of its oxygenated products, have 
been identified as essential early steps of apoptosis culminating in the release of pro-
apoptotic factors11. CL oxygenation is catalyzed by CL/cytochrome c (cyt c) complexes that 
act as a potent CL-specific peroxidase11 via an enzymatic mechanism similar to that of 
COX-2 catalyzed oxygenation of arachidonic acid (AA)12. Given that cyt c-driven reactions 
yield a highly diversified set of oxidized CL (CLox) products, including different stereo-
isomers with hydroperoxy-, hydroxy-, epoxy- and oxo-functionalities13, 14, we hypothesized 
that mitochondrial CLs can be a source of bioactive lipid mediators. While lipid mediators, 
particularly eicosanoids, have been implicated in the regulation of intrinsic and extrinsic 
apoptotic pathways15, mitochondria have not been associated with their biosynthesis. Here 
we report that CL is oxidized to highly diversified polyunsaturated molecular species by cyt 
c thereby, representing a new biosynthetic pathway for lipid mediator production. A rich 
assortment of CLox species subsequently undergoes hydrolysis by Ca2+-independent iPLA2γ 
thus generating multiple oxygenated FAs (FAox) that include well known lipid mediators as 
well as oxygenated species of lyso-CLs with yet to be determined biological functions.
RESULTS
Selective oxidation and hydrolysis of CL in mouse small intestine
To ascertain whether mitochondrial CL can be a source of lipid mediators we performed 
lipidomics analysis of two different tissues - small intestine and brain - after whole body 
irradiation (WBI) and controlled cortical impact (CCI), respectively. In small intestine (a 
radiosensitive tissue) of C57BL6 mice exposed to 10 Gy of WBI, LC/MS analysis revealed: 
i) a decrease of oxidizable polyunsaturated CL molecular species (Fig. 1a), ii) generation of 
CLox (Fig.1b) and iii) accumulation of mono-lyso-cardiolipins (mCLs) (Fig. 1c) and FAox 
(Fig. 1d). CLox were mainly represented by molecular species containing one, two and three 
additional oxygen atoms and their structures were confirmed by MS/MS analysis (Fig. 1b). 
While mCLs mainly included non-oxidized molecular species, both mono- and di-
oxygenated species of mCL (mCLox), particularly with mono- and di-oxygenated LA, were 
also detected (Supplementary Table S1, Supplementary Fig. S1) whereby the mono-
oxygenated mCL derivatives were predominant (Fig. 1c). Quantitatively, the amount of 
detectable CLox (0.12 ± 0.05 pmol/nmol of total phospholipids) was ~2.5 times lower than 
the level of mCL (0.30 ± 0.18 pmol/nmol of total phospholipids). This indicates that the 
hydrolysis reactions – possibly catalyzed by Ca2+-independent iPLA2γ – were effective in 
converting CLox into mCLs. The major FAox species – mostly mono-oxygenated LA-
derivatives - were 9-HODE and 13-HODE (Fig 1d). In addition, 9-KODE, 13-KODE, 9-
HpODE, 13-HpODE, 12-HETE, 15-KETE, 15-HETE were also detectable albeit in 
significantly smaller amounts (Supplementary Fig. S2, Supplementary Table S2).
To ascertain whether iPLA2γ might be accountable for the hydrolysis of CLox leading to the 
generation of mCLs, we utilized 6E- (bromoethylene)tetrahydro-3R- (1-naphthalenyl)-2H-
pyran-2-one, (R)-bromoenol lactone ((R)-BEL), an inhibitor of Ca2+-independent iPLA2γ in 
vivo16. We confirmed that (R)-BEL did not inhibit peroxidase activity of cyt c/CL 
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complexes (Supplementary Table S3). (R)-BEL blocked the irradiation-induced 
accumulation of mCL by 94.9±0.7%. Notably, irradiation induced accumulation of two 
major lyso-phosphatidylcholines (LPC) (16:0-LPC and 18:0-LPC) was not significantly 
affected by (R)-BEL (data not shown). The amount of detectable CLox in the small intestine 
of mice pretreated with (R)-BEL and exposed to WBI was estimated as 0.29 ± 0.15 pmol/
nmol of total phospholipids, a ~2.5-fold increase vs. its content in the absence of the 
inhibitor. Thus iPLA2γ has been mainly responsible for the hydrolysis of CLox and the 
production of mCL. Simultaneously, the total amount of released FAox was inhibited by 
67.3±7.2%. In particular, 12-HETE and 15-HETE concentrations in irradiated intestinal 
samples from (R)-BEL treated animals were 45.7±16.0% and 76.3±28.0% of untreated 
irradiated intestinal samples. Expectedly, the decrease of oxidizable CL species was not 
significantly affected by (R)-BEL (data not shown). Overall, these data emphasize the major 
role of Ca2+-independent iPLA2γ in the generation of mCLs and also reflect the likely 
involvement of other pathways – independent of iPLA2γ – in the formation of FAox.
We next compared the effects of a cocktail of several reportedly effective inhibitors of 
COX-, LOX- and cytochrome P450-driven conventional biosynthetic mechanisms for lipid 
mediators species versus their generation via CL-dependent pathways. Specifically, we 
tested the effects of the inhibitors of: i) COX-1 and -2 - piroxicam (4-hydroxy-2-methyl-
N-2-pyridinyl-2H-1, 2-benzothiazine-3-carboxamide-1,1-dioxide); ii) LOX - licofelone (6- 
(4-chlorophenyl)-2,3-dihydro-2,2-dimethyl-7-phenyl-1H-pyrrolizine-5-acetic acid); and 
cytochrome P450 epoxygenase/12-HETE activity (CYP2C) - MS-PPOH (N-
(methylsulfonyl)-2- (2-propynyloxy)-benzene-hexanamide))17–20 on the formation of FAox 
in the small intestine of irradiated mice. Because all three enzymes – COX, P450 and 5-
LOX – are iron-containing proteins of which the former two are hemoproteins, we assessed 
the effects of inhibitors on the catalytic peroxidase properties of cyt c/CL complexes in 
vitro. Within the range of concentrations corresponding to the doses applied in our in vivo 
experiments, these inhibitors did not suppress the peroxidase activity (Supplementary Table. 
S3). We found that the inhibitor cocktail partially decreased the levels of mono-oxygenated 
AA and oxo-LA compared with the group of mice that received no drugs before irradiation 
(Supplementary Table S4). The production of di-oxygenated LA did not appear to be 
affected by the mixture of inhibitors. This suggests that generation of lipid mediators from 
CL/CLox is accomplished through the enzymatic reactions distinct from the known Ca2+-
dependent mechanisms realized via the release of free FAs and their subsequent 
oxygenation.
Selective oxidation and hydrolysis of CL in rat brain
In rat brain, CLs were highly diversified and included mostly oxidizable polyunsaturated 
CLs (Fig. 2a). LC/MS analysis revealed that CCI caused depletion of oxidizable CLs 
containing LA, AA and docosahexaenoic (DHA) acids (Fig. 2a) and formation of CLox (Fig. 
2b) and its hydrolysis products: mCL (Fig. 2c) and FAox (Fig. 2d). CLox were mainly 
represented by species containing one and two additional oxygen atoms (Fig.2b). MS/MS 
analysis identified mono-oxygenated species of CLox with either LAox or AAox (Fig. 2b). 
mCLs were represented by non-oxidized as well as oxidized mCLox species (Fig. 2c, 
Supplementary Table S1, and Supplementary Fig. S3). The CLox content was lower than the 
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amount of mCL: 0.10 ± 0.02 and 0.26 ± 0.08 pmol/nmol of total phospholipids, respectively. 
In addition, the oxygenated species of non-esterified LA and AA were produced (Fig. 2d, 
Supplementary Fig. S4), whereby several lipid mediators were identified such as 9-KODE, 
13-KODE, 9-HODE, 13-HODE, 9,12,13,-KEpOME, 9-HpODE, 13-HpODE, 12-HETE, 15-
HETE (Supplementary Table S2). Markedly smaller amounts of oxygenated DHA were also 
detected (Fig. 2d). Quantitatively, the CCI-induced loss of CL species containing PUFA was 
in good correspondence with the accumulation of FAox (~5.1 and ~3.0 pmol/nmol of total 
phospholipids, respectively). This indicates that CL can be a source of CCI-induced 
production of FAox.
To ascertain whether the CL/CLox-dependent pathway may be cell type specific, we 
compared the responses of two types of brain cells – cortical neurons and one of the major 
components of glia, astrocytes, to a standard treatment with H2O2 in vitro. We found that 
neurons (Supplementary Fig. S5, Supplementary Table S5) contained more oxidizable 
polyunsaturated CL species than astrocytes (Supplementary Fig. S6, Supplementary Table 
S5). Accordingly, the amounts and speciation of CLox after H2O2 exposure was also 
markedly richer in the former than in the latter (Supplementary Figs. S5 and S6). Similarly, 
the levels and diversification of mCLs was also significantly greater in neurons than in 
astrocytes (Supplementary Figs. S5 and S6).
Generation of oxidized TLCL and its hydrolysis products in mitochondria
To further characterize pathways of CL peroxidation and hydrolysis we utilized C57BL6 
mouse heart and liver mitochondria in which CL was accountable for ~15% of total 
phospholipids (Fig. 3). MS analysis demonstrated that oxidizable LA residues were present 
in all molecular species of CL (Supplemental Fig. S7). After exposure to a pro-oxidant, t-
BuOOH, isolated mitochondria revealed the same pattern of characteristic CL changes as in 
vivo: i) decreased amounts of oxidizable CLs (Fig. 3a) accumulation of non-oxidized mCL 
(Fig. 3b) and LAox, (containing one and two oxygens) (Fig. 3c).
Identification of cytochrome c as the catalyst of CL oxidation and hydrolysis
To directly assess the involvement of cyt c in CL peroxidation and hydrolysis products as a 
source of lipid mediators, we compared the production of mCL and FAox in cyt c+/+ and cyt 
c−/− mouse embryonic cells (MECs) during apoptosis triggered by non-oxidant (actinomycin 
D, ActD) or oxidant (t-BuOOH) stimuli (Fig. 4a). No significant differences were found in 
the total content and molecular speciation of CLs (approximately 3% of total phospholipids; 
31.1±4.9 and 33.7±7.1 pmols CL/nmol total phospholipids, respectively) in cyt c+/+ and cyt 
c−/− cells (Fig. 4b and Supplementary Fig. S8). Treatments with ActD or t-BuOOH caused a 
significant decrease of oxidizable polyunsaturated species of CL and accumulation of CLox 
species with one and two oxygens in cyt c+/+ cells - but not in cyt c−/− - cells (Fig. 4b and 
Supplementary Fig. S8). Quantitatively, the amounts of CLox produced in cyt c+/+ cells 
challenged with either ActD or t-BuOOH were increased 2.6- and 3.0 -times compared to 
untreated controls. Analysis of hydrolysis products revealed the presence of both oxidized 
and non-oxidized mCL (Fig. 4c) as well as oxygenated LA (Fig. 4d). Mono- and di-
oxygenated molecular species of mCLox were the predominant forms accumulating in cells 
upon the treatments (Fig.4c). Mono-oxygenated LA was the main product in ActD treated 
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cyt c+/+ cells and was represented by a mixture of 9-HODE and 13-HODE (Fig. 4d). No 
significant increase in the levels of CLox and CL hydrolysis products was detected in ActD 
and t-BuOOH treated cyt c−/− cells (Fig. 4). Notably, ActD or t-BuOOH triggered apoptosis 
in cyt c+/+ cells as evidenced by a marked increase of PS externalization (Fig. 4a), whereas 
these pro-apoptotic effects were not found in cyt c−/− cells11.
MECs express two isoforms of cyt c – somatic (s-cyt c) and testicular (t-cyt c)21–23. Western 
blot analysis established that t-cyt c was accountable for ~45% of the total cyt c in MECs 
(Supplementary Fig. S9). In cyt c−/− cells, the amount of t-cyt c was ~1.5 times lower than in 
cyt c+/+ cells (0.83 ± 0.05 and 1.24 ± 0.08 ng/µg protein, respectively). As cyt c−/− cells rely 
more on glycolysis rather than mitochondrial respiration for ATP generation24 they maintain 
lower levels of mitochondria. Indeed, Western blots showed that the levels of several 
mitochondrial marker proteins (COX-IV, MnSOD, TIM23) were ~46%–83% lower in cyt 
c−/− cells versus cyt c+/+ cells (Supplementary Fig. S9). siRNA knock-down of the t-cyt c in 
cyt c−/− cells to ~50% of its content (Supplementary Fig. S9) did not affect the already low 
level of CL oxidation after ActD treatment. Similar to cyt c−/− cells the low level of mCL in 
cyt c−/− with knock-down t-cyt c remained unchanged after ActD exposure. These data 
suggest that t-cyt c is not a significant contributor to the generation of CL-driven lipid 
mediators.
Hydrolysis of oxidized TLCL by mitochondrial Ca2+-independent PLA2γ
Ca2+-independent iPLA2γ has been suggested as a likely candidate-catalyst capable to 
hydrolyze oxidized phospholipids in mitochondria25. To assess its role in the hydrolysis of 
CLox species, we bio-synthesized (using cyt c/H2O2 system) and purified (to the level of 
99% using LC/MS) oxidized tetralinoleoyl-cardiolipin (TLCLox with 1–8 oxygens in four 
LA residues, see Supplementary Table S6 and Supplementary Fig. S10) and analyzed the 
products formed in the presence of a specific iPLA2γ inhibitor, (R)-BEL, in rat liver 
mitochondria (Fig. 3d). Mitochondria effectively hydrolyzed TLCLox as evidenced by i) 
decrease of TLCLox content (Fig. 3e) and ii) accumulation of oxygenated LA (with one and 
two oxygens) (Fig. 3f) as well as non-oxidized mCL and mCLox (Fig. 3g,h). The hydrolysis 
of TLCLox was effectively blocked by (R)-BEL (Fig. 3).
Hydrolysis of oxidized TLCL by PAF acetylhydrolase
Mitochondria with externalized CL and/or CLox as well as cyt c can be released into 
circulation during injury/disease process26. Thus circulating CL and CLox can be a source of 
lipid mediators as well. Several phospholipases, including lipoprotein-associated PLA2 
(LpPLA2) or platelet activating factor (PAF) acetylhydrolase (PAF-AH), have been shown 
to selectively hydrolyze oxidatively modified phospholipids to liberate FAox27. Recently, we 
have identified oxidized PS as a good substrate for Lp-PLA228. Because TLCL is the most 
predominant species of CL in circulation, we tested the ability of PAF-AH to release 
oxygenated FAs from TLCLox produced in cyt c driven reaction (Supplementary Fig. S10). 
LC/MS analysis revealed accumulation of mCL containing both LA and LAox (Figs. 5a, 5b, 
5c), whereby LAox was represented by molecular species with one and two oxygens (Fig. 
5d). Markedly less effective hydrolysis was detected when non-oxidized TLCL was treated 
with PAF-AH (data not shown). Thus, PAF-AH predominantly hydrolyzes oxygenated 
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molecular species of CL to generate lipid signaling molecules formed in cyt c catalyzed 
reaction.
Diversity of oxygenated FAs after hydrolysis of brain CLox generated by cyt c/H2O2
The high diversification and enrichment with PUFA of brain lipids makes neuro-CLs 
particularly interesting as a source of lipid mediators generated via CL oxidation by cyt c. 
Indeed, we identified 56 major molecular species of CL in lipid extracts from mouse brain 
(Supplementary Table S7) of which 55 were highly oxidizable polyunsaturated CL 
containing one to four PUFAs (Fig. 6a). To establish molecular identity and stereospecificity 
of peroxidizable PUFA in neuro-CLs we employed a mixture of PLA1 with PLA2 and 
established that the dominant PUFAs of CL were represented by AA and LA (Fig. 6a). 
DHA, EPA, eicosatrienoic and octadecatrienoic acids were detected as well but in relatively 
lower abundance. Cyt c/H2O2 caused significant decrease of PUFA-containing molecular 
species of CL (Fig. 6b and Fig. 6c). By employing PLA1 plus PLA2 as a tool to liberate FA 
from both sn-1 and sn-2 positions of CLox we identified by MS/MS analysis highly 
diversified molecular species of LAox and AAox (Fig. 6d) which included those detected in 
acutely injured tissues (brain after CCI and small intestine after WBI) (Supplementary Table 
S2) as well as in apoptotic cyt c+/+ cells. In addition, oxidatively truncated FA molecular 
species were detected (Supplementary Table S2). Overall, 31 molecular species of FAox 
have been identified as the products of brain CLox hydrolysis.
Discussion
Oxygenated free PUFAs – generated by a wide array of enzymes, including 
cyclooxygenases (COX-1 and COX-2), lipoxygenases (5-LOX, 12-LOX and 15-LOX) and 
cytochrome P450 isoforms [reviewed in5, 7] - have numerous physiological roles. The potent 
biological effects of lipid regulators necessitate the maintenance of very low endogenous 
levels of free PUFA. As a result, their availability is the rate-limiting step in the generation 
of lipid mediators4. Release of PUFA precursors from their phospholipid storage sites is 
achieved via action of Ca2+-dependent phospholipases A2 (PLA2),30. We have reported a 
new Ca2+-independent pathway for selective generation of lipid mediators from a 
mitochondria-specific phospholipid, CL, whereby oxidation of FA residues is catalyzed by 
an intermembrane space protein, cyt c, directly in the esterified phospholipid. This is 
followed by hydrolysis of oxygenated CL species by two types of PLA2 specific towards 
oxidatively modified phospholipids. This novel pathway disobeys the major dogmas of lipid 
mediator biochemistry with regards to: i) oxygenation of a phospholipid rather than a free 
FA as the reaction substrate, ii) mitochondrial – rather than cytosolic - localization- iii) an 
electron carrier cyt c – rather than an oxidase - as the reaction catalyst, iv) the final – rather 
than the initial – hydrolytic stage using oxygenated species of CL by PLA2 to synthesize 
oxygenated PUFA, and v) Ca2+-independent - rather than Ca2+ dependent - nature of the 
pathway.
One can predict specific features of regulation of CL-dependent process that are markedly 
different from the “conventional” biosynthesis of oxygenated lipid mediators. The 
mitochondrial pathway is strictly dependent on the catalytic interactions between cyt c and 
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CL. However, these two participants have limited access to each other. The former is 
confined to the intermembrane space while the latter is “cloaked” almost exclusively in the 
inner mitochondrial membrane31. Importantly, ~15% of cyt c is believed to be 
hydrophobically bound to the IMM likely via its binding to CL in the outer leaflet of the 
IMM and cannot be removed from mitochondria, as occurs to the majority of cyt c upon 
treatment with high ionic strength solutions32. The function of the tightly membrane-bound 
cyt c in normal mitochondria has not been identified. Given that CL-bound cyt c cannot act 
as electron acceptor from respiratory complex III33, we speculate that catalysis of CL-
dependent formation of lipid mediators may represent an unrecognized function of cyt c.
For the peroxidase activity of cyt c/CL complexes, the presence of sufficient amounts of 
oxidizing equivalents such as H2O2 or lipid hydroperoxides (“peroxide tone”34, 35) is 
essential for triggering CL oxidation. Their supply may be driven by disrupted electron 
transport likely occurring as a consequence of cyt c binding with CL34. The complex has a 
redox potential ~400 mV more negative than free cyt c – the effect that precludes cyt c’s 
function as an electron acceptor from mitochondrial complex III33. As a result accumulating 
reduced intermediates serve to donate electrons to molecular oxygen yielding superoxide 
radicals. Spontaneous or catalyzed dismutation of the latter generates H2O2 that feeds the 
catalytic peroxidase cycle of cyt c/CL complexes. This dependency on H2O2 as the source 
of oxidizing equivalents disappears with the accumulation of FA-hydroperoxides or CL-
hydroperoxides that can act as more efficient substrates for the peroxidase half-cycle of the 
process35.
Cells can express, at different proportions, two isoforms of cyt c – s-cyt c and t-cyt c21–24. 
We found that t-cyt c does not significantly contribute to the production of lipid mediators. 
To investigate if there are potential differences in s-cyt c versus t-cyt c participation in lipid 
oxidation, we compared the interaction of two isoforms of cyt c with CL using sequence 
analysis, molecular structural modelling, as well as molecular docking and computational 
simulations. The sequences of s- and t-cyt c and 3D-structures displayed high similarity 
(Supplementary Fig. S12). Further, ligand docking analysis revealed close similarity 
between the two isoforms in binding a typical peroxidation substrate, TLCL, as judged by 
closely matching predicted binding energy values (Supplementary Table S8). Finally, 
coarse-grained molecular dynamics simulations of cyt c interactions with lipid bilayers 
revealed equally avid binding to TLCL-containing membranes at early stages in the 
simulation and lack thereof with lipid bilayers devoid of TLCL (Supplementary Fig. S12). 
This suggests that t-cyt c, like s-cyt c, should be competent towards peroxidase functions, 
including CL peroxidation.
The failure of t-cyt c to operate as a catalyst of CL oxidation in MECs may mostly due to its 
presence as apo-protein whereby its biosynthesis into the catalytically active holo-enzyme 
may be the limiting factor. According to Kim et al., three times more t-cyt c was detected by 
radioimmunoassay, than by spectral assessments of the catalytically competent 
hemoprotein36. Of note, the anti-t-cyt c antibody employed in our study does not distinguish 
between the apo- and holo-proteins. Differences in the localization of these two isoforms of 
cyt c in the intermembrane space and their differential interactions with CLs and other 
proteins may also be contributory to their dissimilar peroxidase activity towards CLs37, 38. 
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The suggested higher pro-apoptotic activity of t-cyt c vs s-cyt c may be realized through 
their differential interactions with pro-caspase complexes (Apaf) and the formation of 
apoptosomes39.
A notable feature of cyt c-catalyzed oxygenation reactions described in this work is 
accumulation of not only of the expected hydroperoxy-CL and hydroxy-CL5 but also the 
presence of epoxy- and oxo-derivatives and truncated products of oxidative cleavage. 
Whether these derivatives are produced by enzymatic cyt c-catalyzed reaction or non-
enzymatic process caused by degradation and release of cyt c’s heme – is unknown. Similar 
products require additional enzymatic activities (i.e., epoxidase, epoxide hydrolases) in the 
traditional pathways triggered by COX and LOX5. Our results with pharmacological 
inhibitors of two different pathways COX/LOX/P450 and (R)-BEL support a role of CL 
oxidation as a source of the generated lipid mediators. In line with our data, disturbed CL re-
acylation in mice with knock-down tafazzin - modeling Barth syndrome - was accompanied 
by the altered pattern of HETE and oxidized LA and DHA metabolites40.
The final step in biosynthesis of oxygenated free FAs requires hydrolysis of oxidatively 
modified CLs by PLA2. Several representatives from different groups of secretory PLA2 
(sPLA2) of a large superfamily of PLA2 were shown to display hydrolyzing activity towards 
peroxidized phospholipids [reviewed in David et al.,29]. Among those, the best studied is 
LpPLA2 – a Ca2+-independent LpPLA2 or type VIIA PLA2 - which can be represented by 
intracellular and secreted forms30 and is active towards oxygenated long-chain and truncated 
forms of PC41. Oxidized PS has been identified as a representative of anionic peroxidized 
phospholipids readily hydrolyzable by Lp-PLA228.
CLs have been identified as signaling molecules in two major biological functions: 
mitophagy42 and apoptosis11. In both cases, CL gets externalized to the mitochondrial 
surface suggesting that any injury to plasma membrane may be associated with the release 
of these “CL-decorated” mitochondria into extracellular environments. Assuming that 
apoptosis commonly transitions to necrosis, mitochondria may – with their externalized CL 
and CLox – act as damage associated molecular patterns (DAMPs)26,43. Our studies reveal 
that not only CL and CLox but also CLox hydrolysis products – mCL and FFAox – may be 
released, along with mitochondria, from injured cells. Importantly, sufficient hydrophobicity 
of mCL retains its association with mitochondria. However, oxygenated mCLs may lose 
their association with the outer mitochondrial membrane and partition into the aqueous 
phase of extracellular compartments. Oxygenated FFAs also water-soluble, hence diffuse 
independently of mitochondrial surfaces. Release of CL44 and cyt c45 from injured host cells 
into the extracellular space, have been shown. Thus lipid mediators may also be generated 
extracellularly from CL with the contribution of cyt c and subsequent hydrolysis of CLox by 
Lp-PLA2. Overall, CL-dependent lipid mediators may be represented by a diversified 
variety of membrane-associated and freely diffusible and circulating signaling molecules 
whose identification and quantitative analysis will represent an intriguing opportunity for the 
future studies.
Brain has an unprecedented diversification of CLs13. By using brain CLs, we showed that a 
significant variety of lipid mediators could be generated by cyt c-catalyzed oxygenation 
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process. In fact, we found that all eight well known LA-based lipid mediators were 
generated by cyt c/H2O2 (Supplementary Table S2). In the AA series, we were able to 
identify nine species of lipid mediators (Supplementary Table S2). A relatively smaller 
number of oxygenated derivatives of docosapentaenoic acid and DHA were detected in spite 
of the significant proportion of these FA residues in brain CLs. Also, terminally 
hydroxylated metabolites of AA, including 17-HETE, 18-HETE, 19-HETE, and 20-HETE 
were not found, implying that terminal hydroxylation reactions are not catalyzed by cyt 
c/H2O2 and are likely formed enzymatically after AA liberation.
The ranking order of FA resiues oxidation in the model biochemical system - where all the 
CL substrates were equally available - was DHA>AA>>LA. The amounts of DHA, AA and 
LA decreased almost 20-, 5- and 0.3-fold, respectively. The energies for H-abstraction in α-
position to bis-allylic double-bonds for different FA with multiple double bonds decrease in 
the order LA<AA<DHA. Accordingly, the propagation rate constants for FA oxidation 
determined for LA (one bis-allylic group), AA (3 bis-allylic groups), EPA (4 bis-allylic 
groups) and DHA (5 bis-allylic groups) increase at ratios of 1, 3.2, 4.0, and 5.446. This is 
consistent with the assumption that the H-abstraction is essential for oxidation of different 
polyunsaturated species of CLs by cyt c’s protein-immobilized Tyr radical: Tyr-O• +CL-H-> 
Tyr-OH +CL•. Thus, preferential oxidation of LA in brain CL’s in vivo does not correlate 
with the chemical reactivity suggesting that CL oxidation in mitochondria is not a simple 
reaction of CLs with cyt c. Availability of CLs for oxidation by cyt c in the inter-membrane 
space likely defines the specificity of the reaction towards different CL species. Our findings 
with brain CLs may provide a long awaited explanation for a well-known large variety of 
CL species in the brain and some other tissues (eg, small intestine, lung) – by implying that 
they are used as precursors for biosynthesis of diversified lipid mediators47.
In conclusion, we describe a new pathway for generation of lipid mediators. This novel 
Ca2+-independent pathway localizes to mitochondria, involves cyt c-catalyzed oxygenation 
of CL esterified PUFA residues, is followed by hydrolysis of oxygenated CL species by two 
types of Ca2+-independent PLA2 specific towards oxidatively modified phospholipids.
Methods
This section describes key experiments only; an extended experimental section is provided 
in the Supplementary Methods.
Controlled cortical impact to the left parietal cortex in 17 day old rats was performed as 
described previously48. For all studies, a 6-mm metal pneumatically driven impactor tip was 
used. The velocity of the impact was 4.0 ± 0.2 m s−1, with a penetration depth of 2.5 mm. 
Whole body irradiation: C57BL/6NHsd female mice were irradiated with dose of 10 Gy 
using a J. L. Shepherd Mark 1 Model 68 cesium irradiator at a dose rate of 80 cGy/min as 
described previously49. 10 Gy of WBI is a LD100/30 for C56Bl6 mice, which means this 
dose causes death of all animals within 30 days after the exposure. Mice were euthanized 10 
or 24 hrs later by CO2 inhalation. All procedures were approved by the IACUC of 
University of Pittsburgh and performed according to the protocols established.
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Analysis of CL and mCL molecular species was performed using a Dionex Ultimate™ 
3000 HPLC system coupled on-line to a linear ion trap mass spectrometer (LXQ, 
ThermoFisher Scientific, San Jose, CA) using Luna 3 µm Silica (2) 100 Å column 
(Phenomenex, Torrance, CA) as described previously28. To analyze oxygenated species, CL 
and mCL were isolated from total lipids by normal phase 2D-HPTLC using mobile phases 
as described by Rouser et al.,50. To prevent lipid oxidation during separation, 
chromatography was performed under N2 conditions on diethylenetriaminepentaacetic acid 
(DTPA) treated silica plates (5 × 5 cm, Whatman). CL and mCL were extracted from silica 
spots49 and used for reverse phase ESI-LC/MS analysis. LC/MS analysis was performed 
using a Dionex UltimateTM 3000 RSLCnano system coupled online Q-Exactive hybrid 
quadrupole-orbitrap mass spectrometer (ThermoFisher Scientific, San Jose, CA) using a C8 
column (Luna 3 µm,100 Å, 150 × 2 mm, Phenomenex, Torrance, CA). For CLox an isocratic 
solvent system consisting of 2-propanol: water: triethylamine: acetic acid, 45:5:0.25:0.25, 
v/v was delivered at 150 µl/min for 20 minutes. For mCLox, a gradient of solvent A 
(acetonitrile: water: triethylamine: acetic acid, 45:5:0.25:0.25 v/v) and B (2-propanol: water: 
triethylamine: acetic acid, 45:5:0.25:0.25, v/v) was used at the flow rate of 150µl/min as 
follows: 0–10 min isocratic at 50% solvent B; 10–20 min linear gradient 50–100% solvent 
B; 20–32 min isocratic at 100% solvent B; 32–35 min linear gradient at 100–50% solvent B; 
35–45 min isocratic at 50% solvent B. Spectra were acquired in negative ion mode using a 
spray voltage of 4.0 kV and a capillary temperature of 320 °C. Scans were acquired in data-
dependent mode with an inclusion list for both CL/CLox, mCL/mCLox species, isolation 
width of 1.0 Da and a normalized collision energy of 24 in high energy collisional 
dissociation (HCD) mode. TMCL-(14:0)4 (Avanti Polar Lipids Inc., Alabaster, AL) and 
mCL-(14:0)3 were used as internal standards. The peaks with signal-to-noise (S/N) ratio of 3 
and higher were taken into consideration.
Detection of oxidized FA. LAox was analyzed by LC/MS using a Dionex Ultimate™ 3000 
HPLC system coupled on-line to LXQ linear ion trap mass spectrometer (ThermoFisher 
Scientific, San Jose, CA). A C18 column (Luna, 3 µm, 150 × 2 mm, Penomenex, Torrance, 
CA) and gradient solvents (A: tetrahydrofuran/methanol/water/CH3COOH, 25:30:50:0.1 
(v/v/v/v) and B: methanol/water 90:10 (v/v)) containing 5 mM ammonium acetate were 
used. The column was eluted at a flow rate of 0.2 mL/min during first 3 min isocratically at 
50% B, from 3 to 23 min with a linear gradient from 50% solvent B to 98% solvent B, then 
23–40 min isocratically using 98% solvent B, 40–42 min with a linear gradient from 98% 
solvent B to 50% solvent B, 42–28 min isocratically using 50% solvent B for equilibration 
of the column. Spectra were acquired in negative ion mode using a spray voltage of 5.0 kV 
and a capillary temperature of 150 °C. Assay method for quantitative assessment of free 
AAox and DHAox was completed as previously described by Miller et al.51 Briefly, LC was 
performed using an acuity ultra-performance LC autosampler (Waters, Milford, MA). 
Separation of analytes was conducted on a UPLC BEH C18, 1.7µm (2.1 × 100 mm) column. 
A gradient mobile phase of 0.005% acetic acid, 5% acetonitrile in deionized water and 
0.005% acetic acid in acetonitrile was used with a run time of 6.4 minutes. Analysis was 
performed using a TSQ Quantum Ultra (ThermoFisher Scientific, San Jose, CA) triple 
quadrupole mass spectrometer with heated electrospray ionization in negative selective 
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reaction monitoring mode. Analytical data were acquired and analyzed using Xcalibur 
software.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Abbreviations and Textual Footnotes
WBI Whole body irradiation
CCI controlled cortical impact
COX cyclooxygenase
LOX lipoxygenase
FA fatty acids
FAox oxygenated fatty acids
PUFA polyunsaturated fatty acids
PUFAox oxygenated PUFAs
LA linoleic acid
LAox oxygenated linoleic acid
AA arachidonic acid
AAox oxygenated arachidonic acid
EPA eicosapentaenoic
DHA docosahexaenoic acid
PS phosphatidylserine
PE phosphatidylethanolamine
PC phosphatidylcholine
PI phosphatidylinositol
PIP2 phosphatidylinositol 4,5-bisphosphate
PLA2 phospholipases A2
iPLA2γ Ca2+-independent iPLA2γ
LpPLA2 Ca2+-independent lipoprotein-associated PLA2
PAF-AH Platelet activating factor-acetylhydrolase
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CL cardiolipin
TMCL tetra-linoleoyl-cardiolipin
TLCL tetra-mirystoyl-cardiolipin
TLCLox oxygenated tetra-linoleoyl-cardiolipin
CLox oxygenated cardiolipin species
mCL mono-lyso-cardiolipin
mCLox oxygenated mono-lyso-cardiolipin
cyt c cytochrome c
s-cyt c somatic isoform of cytochrome c
t-cyt c testicular isoform of cytochrome c
IMM inner mitochondrial membrane
OMM outer mitochondrial membrane
2D-HPTLC two-dimensional high performance thin layer chromatography
MS mass spectrometry
LC/MS liquid chromatography mass spectrometry
9-KODE 9-oxo-octadecadienoic acid
13-KODE 13-oxo-octadecadienoic acid
9-HODE 9-hydroxy-octadecadienoic acid
13-HODE 13-hydroxy-octadecadienoic acid
9,10-EpOME 9,10-epoxy-octadecanoic acid
12,13-EpOME 12,13-epoxy-octadecanoic acid
9,14-KHODE 9-oxo-14-hydroxy-octadecadienoic acid
8,13-HKODE 8-hydroxy-13-oxo-octadecadienoic acid
9,12,13-EpKOME 9-oxo-12,13-epoxy-octadecanoic acid
8,13-DiHODE 8,13-dihydroxy-octadecadienoic acid
8,13-KHpODE 8-oxo-13-hydroperoxy-octadecadienoic acid
8,13-HpKODE 8-hydroperoxy-13-oxo-9,11-octadecadienoic acid
9,14-KHpODE 9-oxo-14-hydroperoxy-octadecadienoic acid
9,14-HpKODE 9-hydroperoxy-14-oxo-10,12-octadecadienoic acid
9,12,13-HpEpOME 9-hydroperoxy-12,13-epoxy-octadecanoic acid
15-KETE 15-oxo-eicosatetraenoic acid
15-HETE 15-hydroxy-eicosatetraenoic acid
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12-HETE 12-hydroxy- eicosatetraenoic acid
17-HETE 17-hydroxy- eicosatetraenoic acid
18-HETE 18-hydroxy- eicosatetraenoic acid
19-HETE 19-hydroxy- eicosatetraenoic acid
20-HETE) 20-hydroxy- eicosatetraenoic acid
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Figure 1. Exposure of mice to whole body irradiation (WBI) causes cardiolipin (CL) oxidation 
and accumulation of its hydrolysis products in small intestine
a, Quantitation of polyunsaturated CL (left) and MS spectra of CL before and after WBI (10 
Gy) (right). Each cluster included 4–5 signals with differing m/z. b, Typical MS spectrum of 
oxidized CL (CLox) obtained 10 hrs after WBI (left) and fragmentation pattern of molecular 
ion with m/z 1463.969 containing oxygenated linoleic acid (LAox) (m/z 295.227). c, 
Quantitation of total monolyso-CL (mCL) (left), MS spectra of mCL (middle) and 
oxygenated mCL (mCLox) (right). Both mono- and di-oxygenated molecular species of 
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mCLox were detected 10 hrs after WBI, whereby the mono-oxygenated mCL species were 
predominant. d, Quantitation of oxygenated polyunsaturated fatty acids (PUFAox) (left) 
accumulated after WBI and MS/MS spectrum of molecular ion with m/z 295 (right). Data 
are presented as pmol/nmol of total phospholipids. Molecular species of PUFAox were 
represented by LAox with m/z 293 (13-KODE, 9-KODE); m/z 295 (13-HODE, 9-HODE, 
9,10-EpOME, 12,13-EpOME); m/z 311 (9-HpODE, 8,13-DiHODE); m/z 325 (9,14-
KHpODE, 9,14-HpKODE, 8,13-KHpODE, 8,13-HpKODE) and oxygenated arachidonic 
acid with m/z 319 (12-HETE) and m/z 317 (15-KETE). Data are means ± S.D., *p < 0.05 vs 
control, n=5.
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Figure 2. Exposure of rats to controlled cortical impact (CCI) causes cardiolipin (CL) oxidation 
and accumulation of its hydrolysis products in brain
a, Quantitation of polyunsaturated CL (left) and MS spectra of CL in control and 3 hrs after 
CCI (right). The spectrum of brain CLs includes nine major clusters of signals with 8–9 
components with differing m/z in each. b, Typical MS spectrum of oxidized CL (CLox) 
(left) and fragmentation pattern of CLox molecular ion with m/z 1491.984 (right) 
represented by two species containing either oxygenated linoleic acid (LAox) (m/z 295.227) 
or arachidonic acid (AAox) (m/z 319.227) and originated from m/z 1475.980. c, Quantitation 
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of total monolyso-CL (mCL) (left) and MS spectra of mCL (middle) and oxygenated mCL 
(mCLox) (right) formed after CCI. Di-oxygenated species of mCLox were detected in injured 
brain. d, Quantitation of major polyunsaturated fatty acids (left) and MS/MS spectrum of 
molecular ion with m/z 319 (right). Data are presented as pmol/nmol of total phospholipids. 
Species of LAox with m/z 293 (13-KODE, 9-KODE); m/z 295 (13-HODE, 9-HODE, 9,10-
EpOME, 12,13-EpOME); m/z 311 (9-HpODE, 8,13-diHODE), m/z 309 (8,13-HKODE, 
9,14-KHODE); m/z 325 (9,14-KHpODE, 9,14-HpKODE, 8,13-KHpODE, 8,13-HpKODE) 
and AAox with m/z 319 (12-HETE,15-HETE) were identified. Small amounts of DHAox 
(m/z 343) were also detected. Data are means ± S.D., *p < 0.05 vs control, n=4.
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Figure 3. Peroxidized cardiolipins (CL) undergo phospholipase A2-catalyzed hydrolysis in 
mitochondria
a, b, c, Oxidation of CL (a) and accumulation of monolyso-CL (mCL) (b) and oxygenated 
fatty acids (FAox) (c) in mouse heart mitochondria treated with t-BuOOH (150 µM). 
Oxygenated linoleic acid (m/z 295 and m/z 311) and oxygenated arachidonic acid (m/z 319 
and 335) containing one and two oxygens were detected. Data are presented as pmols FAox 
per nmol of phospholipids. Data are means ± S.D., *p < 0.05 vs. control, n = 3. d,e,f,g,h, 
Effect of 6E-(bromoethylene)tetrahydro-3R-(1-naphthalenyl)-2H-pyran-2-one, (R)-
bromoenol lactone) (R)-BEL, Ca2+-independent iPLA2γ inhibitor, on hydrolysis of 
exogenous oxidized tetra-linoleyl CL (TLCLox) by mouse liver mitochondria. MS spectra of 
CL obtained from mouse liver mitochondria before and after addition of TLCLox (d). TLCL 
was oxidized by cyt c/H2O2 (see Supplementary Fig.S10). Content of TLCLox (e), FAox (f) 
and mCL (g) in mitochondria incubated with exogenous TLCLox in the presence and in the 
absence of (R)-BEL. MS spectrum of mCL from mitochondria incubated in the presence of 
TLCLox (h). Data are mean ± S.D., *p < 0.05 vs. non-treated mitochondria, n=3.
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Figure 4. Execution of apoptosis is accompanied by cardiolipin (CL) oxidation and accumulation 
of its hydrolysis products in mouse embryonic cyt c+/+ (but not cyt c−/−) cells
a, Assessments of a biomarker of apoptosis, externalized phosphatidylserine, in cyt c+/+ and 
cyt c−/− cells by annexin V binding (left). Flow cytometry data from a representative 
experiment after treatment of cells with ActD (100 ng/mL, 16 hrs): the number of annexin 
V/FITC-positive cells is shown in log scale (right). b) Consumption of CL in either ActD or 
t-BuOOH (200 µM, 16 hrs) treated cyt c+/+ and cyt c−/− cells (left) and MS spectra of CL 
(middle), oxygenated CL (CLox) (right) from cyt c+/+ cells exposed to ActD. c, 
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Accumulation of monolyso-CL (mCL) in either ActD or t-BuOOH treated cyt c+/+ and cyt 
c−/− cells (left) and MS spectra of mCL (middle), oxygenated mCL (mCLox) (right) from cyt 
c+/+ ActD treated cells. d, Accumulation of oxygenated linoleic acid (LAox) in ActD and t-
BuOOH treated cyt c+/+ and cyt c−/− cells (left) and MS/MS fragmentation pattern of LAox 
(m/z 295) (right) formed in ActD treated cyt c+/+ cells. Mono-oxygenated LAox was 
predominantly accumulated and represented by both 9-HODE and 13-HODE. Data are mean 
± S.D., *p < 0.01 vs control, n=3–4.
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Figure 5. Platelet activating factor-acetylhydrolase (PAF-AH) catalyzes hydrolysis of oxygenated 
tetra-linoleyl-CL (TLCL)
a, MS spectra of monolyso-CLs (mCLs) (left) and dilyso-CLs (dCLs) (right) formed during 
PAF-AH-driven hydrolysis of oxygenated TLCL (TLCLox). Arrows show oxygenated mCL 
(mCLox) and dCL (dCLox) species (and their m/z values) with indicated oxygen atoms 
added. b, c, Quantitative assessment of lyso-CLs (b), non-oxygenated and oxygenated 
linoleic acid (LAox) (c) formed during PAF-AH-driven hydrolysis of TLCLox. d, 
Identification and quantification of LAox liberated after hydrolysis of TLCLox by PAF-AH. 
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Molecular ions of LAox with m/z 293 (13-KODE, 9-KODE), m/z 295 (13-HODE, 9-HODE, 
9,10-EpOME, 12,13-EpOME), m/z 309 (8,13-HKODE, 9,14-KHODE), m/z 311 (9-HpODE, 
13-HpODE and 8,13-DiHODE) and m/z 327 (9,12,13-HpEpOME) were detected. Data are 
means ± S.D., *p < 0.05 vs. LA, n=4.
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Figure 6. Cytochrome c (cyt c)/H2O2 induces oxidation of polyunsaturated fatty acid (PUFA) 
residues of cardiolipin (CL) isolated from mouse brain
a, Characterization of polyunsaturated fatty acids (PUFA) esterified to brain CL. Number of 
CL molecular species containing PUFA (left). PUFA distribution in brain CL species (right). 
b, c, MS spectra (b) and quantitative assessment of brain CL molecular species (c) obtained 
before (red) and after (blue) treatment with cyt c in the presence of H2O2. d, Quantitative 
assessment of PUFA of non-oxidized CL (red) and CL exposed to cyt c/H2O2 (blue). *p < 
0.05 vs control (CL not treated with cyt c). Data are means ± S.D., n=3.
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